The FGFR D3 Domain Determines Receptor Selectivity For Fibroblast Growth Factor 21 (Q39578050)

13 September 2017

title

The FGFR D3 Domain Determines Receptor Selectivity For Fibroblast Growth Factor 21 (English)

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

26 November 2024

Jamila Gupte

1 reference

13 September 2017

Li Yang

1 reference

13 September 2017

Xinle Wu

1 reference

13 September 2017

Jennifer Weiszmann

1 reference

13 September 2017

Randy Hecht

1 reference

13 September 2017

Bryan Lemon

1 reference

13 September 2017

Richard Lindberg

1 reference

13 September 2017

Zhulun Wang

1 reference

13 September 2017

Yang Li

1 reference

13 September 2017

language of work or name

English

0 references

publication date

23 March 2011

1 reference

full work available at URL

13 September 2017

1 reference

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0022283611002555?httpAccept=text/xml

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

https://api.elsevier.com/content/article/PII:S0022283611002555?httpAccept=text/plain

26 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Journal of Molecular Biology

26 November 2024

published in

1 reference

13 September 2017

volume

408

1 reference

13 September 2017

1 reference

13 September 2017

page(s)

491-502

1 reference

The FGF family: biology, pathophysiology and therapy

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Fibroblast growth factor (FGF) receptor 1-IIIb is a naturally occurring functional receptor for FGFs that is preferentially expressed in the skin and the brain

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Actions and mode of actions of FGF19 subfamily members

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Fibroblast growth factor 21 corrects obesity in mice

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Glycosaminoglycan affinity of the complete fibroblast growth factor family

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Regulation of fibroblast growth factor-23 signaling by klotho

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

BetaKlotho is required for metabolic activity of fibroblast growth factor 21

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Liver-specific activities of FGF19 require Klotho beta

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Structural basis for FGF receptor dimerization and activation

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Structural basis for fibroblast growth factor receptor activation

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19).

26 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.JMB.2011.03.003

26 November 2024

Identifiers

1 reference

13 September 2017

1 reference